Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

5-HT antibodies for treatment of alcoholism

May 8, 1998

Ro-19-4603 attenuates ethanol responding in alcohol-preferring rats

May 8, 1998

ImmuLogic evaluates cocaine vaccine in phase I

April 21, 1998

Nefiracetam: a potential treatment for PCP addiction?

April 2, 1998

Metadoxine is beneficial in alcoholic patients, even with continued alcohol consumption

March 26, 1998

Effects of EAA receptor antagonists on morphine tolerance and dependence

March 9, 1998

HBED proposed as alternative to deferoxamine as iron chelator

March 2, 1998

Nicotine inhaler launched in U.S.

March 2, 1998

The role of dopamine D2 receptor in alcohol intake suppression

Feb. 17, 1998

Orally active iron chelators in development at Novartis

Feb. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...